IPMC 2025 is an International Precision Medicine and Personalized Medicine conference which gathers experts from all over the globe during March 13-15 at Rome, Italy
Precision medicine seeks to maximize the quality of health care by individualizing the health-care process to the uniquely evolving health status of each patient. This endeavor spans a broad range of scientific areas including drug discovery, genetics/genomics, health communication, and causal ...
case reports, reviews, editorials, and perspectives in the field of precision medicine in a timely manner. The journal covers all aspects of precision medicine, which uses novel means of diagnosis, treatment, and prevention tailored to the needs of a patient or...
US National Library of Medicine. ClinicalTrials.gov http://www.clinicaltrials.gov/ct2/show/NCT02152254 (2017). Tsimberidou, A.-M. et al. Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses. Clin. Cancer Res. 20...
A. Towards precision medicine in the clinic: from biomarker discovery to novel therapeutics. Trends Pharmacol. Sci. 38, 25–40 (2017). CAS PubMed Google Scholar Santoro, A. et al. Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase ...
Expected final online publication date for the Annual Review of Medicine Volume 69 is January 29, 2018. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates. 展开 关键词: whole-genome sequence metabolomics magnetic resonance imaging molecular diagnosis machine learning ...
Provides technological aspects in precision medicine with aspects of modern statistical and bioinformatics models and methods Brings timely reviews on status and chances in precision medicine and associated aspects of data analysis, statistics and data interpretation Encompasses easy access to relevant approach...
Current processes of care for diabetes mellitus (DM) were shaped during the era when insulin therapy was considered inexorable to the management of advance... SS Schwartz,PS Jellinger,ME Herman - 《Postgraduate Medicine》 被引量: 1发表: 2016年 Detecting heart stress using NT-proBNP in patients...
'Precision medicine' and ischaemic heart disease: the stage is set for the new antibody based therapies (lipid lowering and anti-inflammatory) Improving cardiovascular risk assessment requires a 'personalized' approach. Appraisal of well-known cardiovascular risk factors should be integrated with ... ...
of medications. We aim to bridge the gap between the biology of the failing heart, its diverse clinical presentations and the range of medications that we can now use to treat it. We present a roadmap for the future of precision medicine in HF....